F/m Emerald Life Sciences Innovation ETF Rating $46.15 +0.18 (+0.39%) As of 03:03 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort Interest F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.77Holdings in LFSC have an aggregate rating of Moderate Buy based on 332 analyst ratings issued in the past year covering 25 companies (91.9% of the portfolio).LFSC Aggregate Price Target$46.15High Prediction$46.15Average Prediction$46.15Low Prediction$46.15Holdings in LFSC have an aggregate price target of $46.15 and a range of $46.15 to $46.15 covering 25 companies (91.9% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.43%TVTXTravere Therapeutics$66.54-1.0%1.6624 of 5 stars2.69$61.67 -7.3%13Positive News7.58%SYRESpyre Therapeutics$87.25+0.2%2.6119 of 5 stars2.87$109.69 25.7%15Trending NewsAnalyst ForecastInsider Trade7.01%COGTCogent Biosciences$34.95+1.1%2.4702 of 5 stars2.75$51.56 47.5%12Positive News6.50%LIVNLivaNova$81.20-1.5%2.5556 of 5 stars2.55$84.13 3.6%11Analyst ForecastInsider Trade6.46%CORTCorcept Therapeutics$112.80+2.1%4.2363 of 5 stars2.50$138.17 22.5%85.86%GHGuardant Health$161.04-1.2%3.0988 of 5 stars2.96$183.78 14.1%25Positive NewsAnalyst Forecast4.67%MIRMMirum Pharmaceuticals$100.63+0.8%3.6639 of 5 stars2.93$137.31 36.5%15Positive NewsInsider Trade3.62%CYTKCytokinetics$73.95+2.8%2.8321 of 5 stars2.85$103.37 39.8%20Analyst ForecastInsider TradeGap Up3.34%BLLNBilliontoone$99.50+3.5%4.2046 of 5 stars2.45$125.88 26.5%11News CoverageAnalyst Downgrade3.20%AXSMAxsome Therapeutics$208.35-0.7%4.1978 of 5 stars2.91$267.60 28.4%22Analyst ForecastInsider Trade3.19%UTHRUnited Therapeutics$490.24-0.4%4.7382 of 5 stars2.85$646.00 31.8%13Trending NewsInsider Trade3.08%MANEVeradermics$97.70-0.8%2.777 of 5 stars2.67$153.00 56.6%93.07%NKTRNektar Therapeutics$76.37+5.0%2.5014 of 5 stars2.77$141.50 85.3%132.95%SVRASavara$5.37-1.6%2.214 of 5 stars2.88$10.14 88.9%8Positive News2.90%TMDXTransMedics Group$86.98+3.2%4.4431 of 5 stars2.38$124.18 42.8%13Analyst Upgrade2.79%DNTHDianthus Therapeutics$107.85+1.5%2.1778 of 5 stars2.93$124.27 15.2%14Positive NewsInsider Trade2.68%TRVITrevi Therapeutics$17.06+0.1%3.4427 of 5 stars3.00$27.08 58.8%13Positive News2.42%VRDNViridian Therapeutics$22.96+0.8%3.4392 of 5 stars2.85$38.54 67.9%13Positive News2.31%ICUIICU Medical$166.29-2.1%3.9355 of 5 stars2.89$192.80 15.9%9Positive NewsInsider Trade2.13%PVLAPalvella Therapeutics$155.47+1.6%2.6603 of 5 stars3.00$209.14 34.5%15Positive News1.98%CRVSCorvus Pharmaceuticals$14.65+3.2%3.0779 of 5 stars2.88$33.33 127.5%8News Coverage1.78%TWSTTwist Bioscience$128.71-1.7%1.6586 of 5 stars2.70$98.30 -23.6%10Positive News1.61%CBLLCeriBell$24.57-1.0%1.4337 of 5 stars2.71$24.40 -0.7%7Positive NewsAnalyst Forecast1.21%HNGEHinge Health$91.03-0.9%3.4201 of 5 stars2.83$100.57 10.5%181.11%GMEDGlobus Medical$78.13-3.1%4.712 of 5 stars2.88$101.77 30.3%17Analyst Revision This page (NASDAQ:LFSC) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
